BioPharma Resources

Drug Trial Radar · NCT07496567

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

A Randomized Double-masked, Multicenter, 3-arm, Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) EYE201/MK-8748 Compared to Aflibercept (2 mg) in Participants With Neovascular Age-related Macular Degeneration (NVAMD)

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Title says "pivotal". Randomized with 960 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

960

Planned (sponsor's estimate)

Start

Apr 15, 2026

Primary completion

Jul 31, 2028

Study completion Jul 31, 2028

Sponsor

Lead sponsor
EyeBiotech Ltd.Industry
Sponsor type
Industry
First posted
Mar 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD). Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD. The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.

Conditions

  • Macular Degeneration
  • Age-Related Macular Degeneration
  • Choroidal Neovascularization
  • Wet Macular Degeneration

Interventions

  • TiespectusDrug

    Administered by intravitreal (IVT) injection

  • AfliberceptDrug

    Administered by intravitreal (IVT) injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change in Best-Corrected Visual Acuity (BCVA) [Early Treatment of Diabetic Retinopathy Study (ETDRS Letters)] From Baseline to Year 1Time frame: Baseline and Year 1

Locations

121 sites in 13 countries. Site status is shown where the registry gives one.

  • Associated Retina Consultants - Gilbert

    Gilbert, Arizona · Recruiting

  • Associated Retina Consultants - Phoenix

    Phoenix, Arizona · Recruiting

  • The Retina Partners

    Encino, California · Recruiting

  • Northern California Retina Vitreous Associates Medical Group, Inc.

    Mountain View, California · Recruiting

  • Orange County Retina Medical Group

    Santa Ana, California · Recruiting

  • Bay Area Retina Associates

    Walnut Creek, California · Recruiting

  • Retina Consultants of Southern Colorado

    Colorado Springs, Colorado · Recruiting

  • RSC Research LLC

    Denver, Colorado · Recruiting

  • Southwest Retina Research Center, LLC

    Durango, Colorado · Recruiting

  • Retina Consultants of Southern Colorado

    Pueblo, Colorado · Recruiting

  • Connecticut Eye Consultants, P.C.

    Danbury, Connecticut · Recruiting

  • Coastal Eye Surgeons

    Greenwich, Connecticut · Recruiting

  • Retina Consultants, P.C.

    Manchester, Connecticut · Recruiting

  • Retina Group of New England

    Waterford, Connecticut · Recruiting

  • Retina Group of Florida

    Fort Myers, Florida · Recruiting

  • Florida Retina Institute

    Orlando, Florida · Recruiting

  • Retina Group of Florida (Site 065)

    Sarasota, Florida · Recruiting

  • Center for Retina and Macular Disease (Site 062)

    Winter Haven, Florida · Recruiting

  • Illinois Retina Associates

    Joliet, Illinois · Recruiting

  • University Retina & Macula Associates, P.C.

    Lemont, Illinois · Recruiting

  • Wolfe Eye Clinic

    West Des Moines, Iowa · Recruiting

  • Retina Associates, LLC

    Lenexa, Kansas · Recruiting

  • Butchertown Clinical Trials

    Louisville, Kentucky · Recruiting

  • Maine Eye Center (Site 097)

    Portland, Maine · Recruiting

  • Mid Atlantic Retina Specialists

    Hagerstown, Maryland · Recruiting

  • Retina Specialists

    Towson, Maryland · Recruiting

  • Retina Research Institute at New England Retina Consultants, PC

    Springfield, Massachusetts · Recruiting

  • Retina Consultants of Minnesota

    Edina, Minnesota · Recruiting

  • Envision Ocular, LLC

    Bloomfield, New Jersey · Recruiting

  • Long Island Vitreoretinal Consultants / Vitreoretinal Consultants of NY

    Great Neck, New York · Recruiting

  • Retina Associates of Western NY, PC (Site 051)

    Rochester, New York · Recruiting

  • Asheville Eye Associates, Retina Division (Site 077)

    Asheville, North Carolina · Recruiting

  • NC Retina

    Cary, North Carolina · Recruiting

  • Graystone Eye

    Hickory, North Carolina · Recruiting

  • NC Retina Associates

    Wake Forest, North Carolina · Recruiting

  • Retina Consultants, LLC

    Salem, Oregon · Recruiting

  • Cascade Medical Research Institute, LLC

    Springfield, Oregon · Recruiting

  • Erie Retina Research

    Erie, Pennsylvania · Recruiting

  • Eye Care Specialists

    Kingston, Pennsylvania · Recruiting

  • Charleston Neuroscience Institute (Site 034)

    Beaufort, South Carolina · Recruiting

Showing 40 of 121 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.